WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int.

Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239–42. https://doi.org/10.1001/jama.2020.2648.

Article  CAS  PubMed  Google Scholar 

Cellina M, Orsi M, Valenti Pittino C, Toluian T, Oliva G. Chest computed tomography findings of COVID-19 pneumonia: pictorial essay with literature review. Jpn J Radiol. 2020;38:1012–9. https://doi.org/10.1007/s11604-020-01010-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu M, Zeng W, Wen Y, Zheng Y, Lv F, Xiao K. COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia. Eur Radiol. 2020;30:5463–9. https://doi.org/10.1007/s00330-020-06928-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Udompongpaiboon P, Reangvilaikul T, Vattanavanit V. Predicting mortality among patients with severe COVID-19 pneumonia based on admission vital sign indices: a retrospective cohort study. BMC Pulm Med. 2023;23:342. https://doi.org/10.1186/s12890-023-02643-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Domingo P, Mur I, Pomar V, Corominas H, Casademont J, de Benito N. The four horsemen of a viral apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19). EBioMedicine. 2020;58: 102887. https://doi.org/10.1016/j.ebiom.2020.102887.

Article  PubMed  PubMed Central  Google Scholar 

Vahabi M, Ghazanfari T, Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int Immunopharmacol. 2022;112: 109183. https://doi.org/10.1016/j.intimp.2022.109183.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shu H, Wang S, Ruan S, Wang Y, Zhang J, Yuan Y, Liu H, Wu Y, Li R, Pan S, et al. Dynamic changes of antibodies to SARS-CoV-2 in COVID-19 patients at early stage of outbreak. Virol Sin. 2020;35:744–51. https://doi.org/10.1007/s12250-020-00268-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woo PCY, Lau SKP, Wong BHL, Chan K, Chu C, Tsoi H, Huang Y, Peiris JSM, Yuen K. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) Coronavirus nucleocapsid protein in patients with pneumonia due to the SARS Coronavirus. Clin Diagn Lab Immunol. 2004;11:665–8. https://doi.org/10.1128/CDLI.11.4.665-668.2004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, Bächli E, Rudiger A, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13:446. https://doi.org/10.1038/s41467-021-27797-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, Tong Q, Yi J, Zhao L, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55: 102763. https://doi.org/10.1016/j.ebiom.2020.102763.

Article  PubMed  PubMed Central  Google Scholar 

Siracusano G, Brombin C, Pastori C, Cugnata F, Noviello M, Tassi E, Princi D, Cantoni D, Malnati MS, Maugeri N, et al. Profiling antibody response patterns in COVID-19: spike S1-reactive IgA signature in the evolution of SARS-CoV-2 infection. Front Immunol. 2021;12: 772239. https://doi.org/10.3389/fimmu.2021.772239.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Tamimi M, Tarifi AA, Qaqish A, Abbas MM, Albalawi H, Abu-Raideh J, Salameh M, Khasawneh AI. Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals. PLoS ONE. 2023;18: e0281689. https://doi.org/10.1371/journal.pone.0281689.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, Cheng L, Li Y, Ma X, Jin T. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020;17:773–5. https://doi.org/10.1038/s41423-020-0474-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Georgakopoulou V, Gkoufa A, Tsakanikas A, Makrodimitri S, Karamanakos G, Basoulis D, Voutsinas P, Eliadi I, Bougea A, Spandidos D, et al. Predictors of COVID-19-associated mortality among hospitalized elderly patients with dementia. Exp Ther Med. 2023;26:395. https://doi.org/10.3892/etm.2023.12094.

Article  PubMed  PubMed Central  Google Scholar 

Al-Mughales JA, Al-Mughales TJ, Saadah OI. Monitoring specific IgM and IgG production among severe COVID-19 patients using qualitative and quantitative immunodiagnostic assays: a retrospective cohort study. Front Immunol. 2021;12: 705441. https://doi.org/10.3389/fimmu.2021.705441.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aleem A, Akbar Samad AB, Vaqar S. Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19). In StatPearls (StatPearls Publishing); 2024

Re3data.Org (2012). GISAID. https://doi.org/10.17616/R3Q59F.

Troyano-Hernáez P, Reinosa R, Holguín Á. Evolution of SARS-CoV-2 in Spain during the first two years of the pandemic: circulating variants, amino acid conservation, and genetic variability in structural, non-structural, and accessory proteins. Int J Mol Sci. 2022;23(12):6394. https://doi.org/10.3390/ijms23126394.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Viedma E, Dahdouh E, González-Alba JM, González-Bodi S, Martínez-García L, Lázaro-Perona F, Recio R, Rodríguez-Tejedor M, Folgueira MD, Cantón R, Delgado R, García-Rodríguez J, Galán JC, Mingorance J, On Behalf Of The Sars-CoV-Working Groups. Genomic epidemiology of SARS-CoV-2 in Madrid, Spain, during the first wave of the pandemic: fast spread and early dominance by D614G variants. Microorganisms. 2021;9(2):454. https://doi.org/10.3390/microorganisms9020454.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scialpi M, Scialpi S, Piscioli I, Battista Scalera G, Longo F. Pulmonary thromboembolism in critical ill COVID-19 patients. Int J Infect Dis. 2020;95:361–2. https://doi.org/10.1016/j.ijid.2020.04.056.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–43. https://doi.org/10.1001/jamainternmed.2020.0994.

Article  CAS  PubMed  Google Scholar 

Rong Y, Wang F, Li X, Liang X, Zhou Y, Zhang D, Liu J, Zeng H, Wang J, Shi Y. Correlation of the ratio of IgM/IgG concentration to days after symptom onset (IgM/T or IgG/T) with disease severity and outcome in non-critical COVID-19 patients. Am J Transl Res. 2021;13:1197–208.

CAS  PubMed  PubMed Central  Google Scholar 

Joseph G, Cohen C, Rubin C, Murad H, Indenbaum V, Asraf K, Weiss-Ottolenghi Y, Segal-Lieberman G, Kreiss Y, Lustig Y, et al. Humoral immunity of unvaccinated COVID-19 recovered vs. Naïve BNT162b2 vaccinated individuals: a prospective longitudinal study. Microorganisms. 2023;11:1628. https://doi.org/10.3390/microorganisms11071628.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vazquez-Zapien GJ, Martinez-Cuazitl A, Sanchez-Brito M, Delgado-Macuil RJ, Atriano-Colorado C, Garibay-Gonzalez F, Sanchez-Monroy V, Lopez-Reyes A, Mata-Miranda MM. Comparison of the immune response in vaccinated people positive and negative to SARS-CoV-2 employing FTIR spectroscopy. Cells. 2022;11:3884. https://doi.org/10.3390/cells11233884.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Staats LAN, Pfeiffer H, Knopf J, Lindemann A, Fürst J, Kremer AE, Hackstein H, Neurath MF, Muñoz LE, Achenbach S, et al. IgA2 antibodies against SARS-CoV-2 correlate with NET formation and fatal outcome in severely diseased COVID-19 patients. Cells. 2020;9:2676. https://doi.org/10.3390/cells9122676.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–8. https://doi.org/10.1016/j.jaci.2020.04.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13: eabd2223. https://doi.org/10.1126/scitranslmed.abd2223.

Article  CAS  PubMed  Google Scholar 

Zervou FN, Louie P, Stachel A, Zacharioudakis IM, Ortiz-Mendez Y, Thomas K, Aguero-Rosenfeld ME. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol. 2021;93:5409–15. https://doi.org/10.1002/jmv.27058.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esmat K, Jamil B, Kheder RK, Kombe Kombe AJ, Zeng W, Ma H, Jin T. Immunoglobulin A response to SARS-CoV-2 infection and immunity. Heliyon. 2024;10: e24031. https://doi.org/10.1016/j.heliyon.2024.e24031.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leong KW, Ding JL. The unexplored roles of human serum IgA. DNA Cell Biol. 2014;33:823–9. https://doi.org/10.1089/dna.2014.2639.